Trial Profile
A phase III registrational trial of bivalirudin in China
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Feb 2017
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary)
- Indications Heparin-induced thrombocytopenia and thrombosis syndrome
- Focus Registrational; Therapeutic Use
- 08 Feb 2017 New trial record